VPS35 and frontotemporal dementia: Interestingly, Vps35’s expression was selectively reduced in the frontal lobe of patients with FTD-TDP carrying Progranulin (PGRN) mutations, but not in FTD-TDP patients without PGRN mutation, as compared with unaffected controls (Fig. 5g).